Tweetovi

Blokirali ste korisnika/cu @FAndreMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FAndreMD

  1. proslijedio/la je Tweet

    With Europe’s beating Cancer Plan we can make a difference together: ✔️ With prevention and research ✔️ With equal access across Europe ✔️ Standing at the side of those who need us.

    Poništi
  2. 4. velj

    The minister of health visited today. A good opportunity to discuss survivorship, early detection, AI, innovation and in general how to integrate research and innovation in daily care.

    Poništi
  3. 3. velj

    precision medicine is "just" the concept behind endocrine therapy and trastuzumab in breast cancer, two drugs that cure several 100 000's live a year. I would not call this paper a "reality check on PM" but a "personal opinion on genomics"...

    Poništi
  4. 2. velj
    Poništi
  5. proslijedio/la je Tweet
    31. sij

    Fantastic article just published in by Ben Deneen’s lab focused on glioma hyper excitability and new synapse formation through PIK3CA variants

    Poništi
  6. proslijedio/la je Tweet
    1. velj

    This paper describing the clinical presentation, outcomes and mutational landscape of ER+/HER2- & triple-negative metastatic harboring PIK3CA mutations from SAFIR02 highlights the potential for new drug development

    Poništi
  7. proslijedio/la je Tweet
    31. sij

    Single-cell nucleic acid sequencing has become an essential biomedical research tool. Now makes a strong case that single-cell proteomics will yield another dimension of vital insights w/

    Poništi
  8. 28. sij

    In this paper; investigators evaluate Raf inhibitor in V600E and non V600E mutant nsclc, and reinforce the concept that a companion diagnostic should meet a precise definition and not only "raf mutated" cancer.

    Poništi
  9. 28. sij

    3.5 M euros collected for the research on childhood cancers during the diner yesterday evening. Transformative results mandatory . Led by . Join the effort !

    Poništi
  10. proslijedio/la je Tweet
    25. sij

    Dr. Aurelien Marabelle presents KEYNOTE-158, second-line pembrolizumab in advanced anal squamous cell carcinoma. Median OS 11.9 months.

    Poništi
  11. 27. sij

    . will provide additional 4 M euros to CANTO: a. extend follow up of the 12000 pts >5y b. increase the nb of young pts c. create cohorts of patients treated w new drugs d. collect new sources of biosamples (feces...) the project should be sustainable in 4 yrs

    Poništi
  12. 27. sij

    In pts with HR+/HER2- mBC eligible to 1st line chemotherapy, PIK3CA mutation is associated with chemoresistance and a poor outcome. These data consolidate the unmet medical need

    Poništi
  13. proslijedio/la je Tweet
    25. sij

    In this study of sunscreen application by healthy pts, all 6 of the tested active ingredients administered in 4 sunscreen formulations were systemically absorbed and had plasma concentrations surpassing thresholds for waiving safety studies

    Poništi
  14. proslijedio/la je Tweet
    8. sij

    Our latest paper in Annals of Oncology found that after treatment for CIN women are still at increased risk of future cervical cancer, and also other HPV-related cancers. This risk remains elevated for 20+ years.

    Poništi
  15. 24. sij

    I have the privilege to sit in a panel of and it s truly amazing how people are professional, kind and how the process of grant selection is fair. Panels are always full of international experts. British colleagues and donnors can trust it.

    Poništi
  16. 22. sij
    Poništi
  17. proslijedio/la je Tweet
    20. sij

    Online : “The single-cell pathology landscape of breast cancer”

    Poništi
  18. 20. sij

    we must find solutions to make careers of clinician scientists more attractive. CS are the ones translating basic concepts and innovation to patients. need for action . V proud to sign this paper w

    Poništi
  19. proslijedio/la je Tweet
    18. sij

    📣 New ESMO consensus recommendations on 'Management of cardiac disease in pts throughout oncological treatment' 👉 Read more on the prevention, detection & treatment of

    Poništi
  20. 18. sij

    Important paper. 2 key concepts: the axes of health data and the "deep cohorts". Deep cohorts should be considered by research agencies when it's about addressing questions that require multidimensional data (+ deep cohorts can be meta-analyzed and include a small control arm)

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·